Ruma Banerjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruma Banerjee has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Omer Kabil
From the Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109,
3 shared publications Anna Prudova
Redox Biology Center and Biochemistry Department, University of Nebraska, Lincoln, NE 68588-0664, USA
2 shared publicationsCarmen Gherasim
Department of Biological Chemistry, University of Michigan, Ann Arbor (USA)
2 shared publicationsVictor Vitvitsky
Redox Biology Center and Biochemistry Department, University of Nebraska, Lincoln, NE 68588-0664; and
2 shared publicationsÖmer Kabil
Department of Biochemistry, University of Nebraska, Lincoln, Nebraska, 68588-0664
2 shared publicationsAaron Braun
Redox Biology Center and Biochemistry Department, University of Nebraska, Lincoln, NE 68588-0664; and
1 shared publication
Latest Publications
- 1 November 2014
- Published by Elsevier in Nitric Oxide
- Vol. 42, 134
Human persulfide dioxygenase and a bacterial variant fused to rhodanese
- 1 November 2014
- Published by Elsevier in Nitric Oxide
- Vol. 42, 134
Human persulfide dioxygenase and a bacterial variant fused to rhodanese
- Open Access
- 1 February 2013
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 52 (9) , 2376
Inside Cover: Access to Organometallic Arylcobaltcorrins through Radical Synthesis: 4-Ethylphenylcobalamin, a Potential “Antivitamin B12” (Angew. Chem. Int. Ed. 9/2013)
- 1 February 2013
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 52 (9) , 2376
Open AccessInside Cover: Access to Organometallic Arylcobaltcorrins through Radical Synthesis: 4-Ethylphenylcobalamin, a Potential “Antivitamin B12” (Angew. Chem. Int. Ed. 9/2013)
- 1 September 2012
- Published by Elsevier in Nitric Oxide
- Vol. 27, S40
P66 Characterization of wild type and patient-described mutant forms of Human Persulfide Dioxygenase, ETHE1
- 1 September 2012
- Published by Elsevier in Nitric Oxide
- Vol. 27, S40
P66 Characterization of wild type and patient-described mutant forms of Human Persulfide Dioxygenase, ETHE1
- 1 September 2012
- Published by Elsevier in Nitric Oxide
- Vol. 27, S12
P2 High turnover rates for hydrogen sulfide in murine tissues
- 1 September 2012
- Published by Elsevier in Nitric Oxide
- Vol. 27, S12
P2 High turnover rates for hydrogen sulfide in murine tissues
- 6 September 2007
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (10) , 1028-1033
Polymorphic background of methionine synthase reductase modulates the phenotype of a disease-causing mutation
Methionine synthase reductase (MTRR) is the locus of the cblE class of inborn errors of cobalamin metabolism that is characterized by megaloblastic anemia and homocystinuria. Two highly prevalent SNPs, c.66A>G (p.Ile22Met) and c.524C>T (p.Ser175Leu), are found in the MTRR gene. On the basis of the allele frequency of these amino acids and sequence comparison with members of the same family of proteins, the p.Ile22/p.Ser175 sequence is designated as wild type. While characterizing a pathogenic methionine synthase reductase (MSR) mutation, c.166G>A (p.Val56Met), we discovered an interaction between the mutation and one of the polymorphic sites. Thus, when the p.Val56Met mutant was initially expressed in the p.Ile22/p.Ser175 background, we were surprised to find that kinetically, it was virtually indistinguishable from wild-type protein. To determine if the polymorphisms interacted with the p.Val56Met mutation, it was expressed in all four possible genetic backgrounds. We found that in the p.Ile22Met background, the p.Val56Met mutation impacted the kinetics of MSR and an approximately three- to 10-fold higher concentration of the p.Ile22Met/p.Val56Met mutant was required for maximal activation of methionine synthase vs. the range seen with wild-type MSR variants. A comparable (three- to seven-fold) diminution in MSR activity was observed in extracts of fibroblast cells from patients carrying the p.Val56Met mutation on one MSR allele and a null mutation on the other. These results predicted that the patient allele encodes the p.Val56Met mutation and the p.Ile22Met variation, which was confirmed by sequence analysis. This study reveals how a genetic variation can modulate phenotypic expression of a disease-causing mutation. Hum Mutat 28(10), 1028–1033, 2007. Published 2007 Wiley-Liss, Inc.
- 6 September 2007
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (10) , 1028-1033
Polymorphic background of methionine synthase reductase modulates the phenotype of a disease-causing mutation
Methionine synthase reductase (MTRR) is the locus of the cblE class of inborn errors of cobalamin metabolism that is characterized by megaloblastic anemia and homocystinuria. Two highly prevalent SNPs, c.66A>G (p.Ile22Met) and c.524C>T (p.Ser175Leu), are found in the MTRR gene. On the basis of the allele frequency of these amino acids and sequence comparison with members of the same family of proteins, the p.Ile22/p.Ser175 sequence is designated as wild type. While characterizing a pathogenic methionine synthase reductase (MSR) mutation, c.166G>A (p.Val56Met), we discovered an interaction between the mutation and one of the polymorphic sites. Thus, when the p.Val56Met mutant was initially expressed in the p.Ile22/p.Ser175 background, we were surprised to find that kinetically, it was virtually indistinguishable from wild-type protein. To determine if the polymorphisms interacted with the p.Val56Met mutation, it was expressed in all four possible genetic backgrounds. We found that in the p.Ile22Met background, the p.Val56Met mutation impacted the kinetics of MSR and an approximately three- to 10-fold higher concentration of the p.Ile22Met/p.Val56Met mutant was required for maximal activation of methionine synthase vs. the range seen with wild-type MSR variants. A comparable (three- to seven-fold) diminution in MSR activity was observed in extracts of fibroblast cells from patients carrying the p.Val56Met mutation on one MSR allele and a null mutation on the other. These results predicted that the patient allele encodes the p.Val56Met mutation and the p.Ile22Met variation, which was confirmed by sequence analysis. This study reveals how a genetic variation can modulate phenotypic expression of a disease-causing mutation. Hum Mutat 28(10), 1028–1033, 2007. Published 2007 Wiley-Liss, Inc.
- 1 September 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1769 (9-10) , 532-540
Translational regulation of human methionine synthase by upstream open reading frames
- 1 September 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
- Vol. 1769 (9-10) , 532-540
Translational regulation of human methionine synthase by upstream open reading frames
- 13 March 2007
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (13) , 4110-4116
A Pathogenic Linked Mutation in the Catalytic Core of Human Cystathionine β-Synthase Disrupts Allosteric Regulation and Allows Kinetic Characterization of a Full-Length Dimer
Cystathionine β-synthase catalyzes the condensation of serine and homocysteine to yield cystathionine and is the single most common locus of mutations associated with homocystinuria. In this study, we have examined the kinetic consequences of a pair of linked patient mutations, P78R/K102N, that are housed in the catalytic core of the protein and compared it to the effects of the corresponding single mutations. The P78R mutation affords purification of a mixture of higher order oligomers, P78R-I, which resembles the mixed quaternary state associated with wild-type enzyme. However, unlike wild-type enzyme, P78R-I converts over time to P78R-II, which exists predominantly as a full-length dimer. The specific activities of the K102N, P78R-I, and P78R-II mutants in the absence of AdoMet are ∼3-, 9-, and 3-fold lower than of wild-type enzyme and are stimulated 2.9-, 2.5-, and 1.4-fold respectively by AdoMet. However, when linked, the specific activity of the resulting double mutant is comparable to that of wild-type enzyme but it is unresponsive to AdoMet, revealing that interactions between the two sites modulate the phenotype of the enzyme. Steady-state kinetic analysis for the double mutant reveals a sigmoidal dependence on homocysteine that is not observed with wild-type enzyme, which is ascribed to the mutation at the K102 locus and indicates changes in subunit interactions. Hydrogen−deuterium mass spectrometric analysis reveals that, even in the absence of AdoMet, the double mutant is locked in an activated conformation that is observed for wild-type enzyme in the presence of AdoMet, providing a structural rationale for loss of this allosteric regulation. To our knowledge, this is the first example of mutations in the catalytic core of cystathionine β-synthase that result in failure of AdoMet-dependent regulation. Furthermore, analysis of individual single mutations has permitted, for the first time, partial kinetic characterization of a full-length dimeric form of human cystathionine β-synthase.
- 13 March 2007
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (13) , 4110-4116
A Pathogenic Linked Mutation in the Catalytic Core of Human Cystathionine β-Synthase Disrupts Allosteric Regulation and Allows Kinetic Characterization of a Full-Length Dimer
Cystathionine β-synthase catalyzes the condensation of serine and homocysteine to yield cystathionine and is the single most common locus of mutations associated with homocystinuria. In this study, we have examined the kinetic consequences of a pair of linked patient mutations, P78R/K102N, that are housed in the catalytic core of the protein and compared it to the effects of the corresponding single mutations. The P78R mutation affords purification of a mixture of higher order oligomers, P78R-I, which resembles the mixed quaternary state associated with wild-type enzyme. However, unlike wild-type enzyme, P78R-I converts over time to P78R-II, which exists predominantly as a full-length dimer. The specific activities of the K102N, P78R-I, and P78R-II mutants in the absence of AdoMet are ∼3-, 9-, and 3-fold lower than of wild-type enzyme and are stimulated 2.9-, 2.5-, and 1.4-fold respectively by AdoMet. However, when linked, the specific activity of the resulting double mutant is comparable to that of wild-type enzyme but it is unresponsive to AdoMet, revealing that interactions between the two sites modulate the phenotype of the enzyme. Steady-state kinetic analysis for the double mutant reveals a sigmoidal dependence on homocysteine that is not observed with wild-type enzyme, which is ascribed to the mutation at the K102 locus and indicates changes in subunit interactions. Hydrogen−deuterium mass spectrometric analysis reveals that, even in the absence of AdoMet, the double mutant is locked in an activated conformation that is observed for wild-type enzyme in the presence of AdoMet, providing a structural rationale for loss of this allosteric regulation. To our knowledge, this is the first example of mutations in the catalytic core of cystathionine β-synthase that result in failure of AdoMet-dependent regulation. Furthermore, analysis of individual single mutations has permitted, for the first time, partial kinetic characterization of a full-length dimeric form of human cystathionine β-synthase.
- 12 March 2007
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 24 (3) , 631-639
Properties of an unusual heme cofactor in PLP-dependent cystathionine β-synthase
Covering: up to 2006 Cystathionine β-synthase is a pyridoxal phosphate (PLP)-dependent hemeprotein, which catalyzes the condensation of serine and homocysteine to give cystathionine, the first step in the transsulfuration pathway. The association of heme with this enzyme in some organisms, including humans, is novel since this combination of cofactors has not been seen in any other protein to date. While the role of PLP in the reaction is suggested by the beta replacement reaction that is catalyzed, the role of the heme is not yet well established. Spectroscopic studies reveal that the heme iron is coordinately saturated in the ferric and ferrous states and is relatively inert to ligand exchange in the oxidized state. The in vitro activity of cystathionine β-synthase is sensitive to the redox state of the heme and is higher in the ferric form. Both CO and NO bind to ferrous heme and inhibit the enzyme. The crystal structure of the protein reveals that the heme is ∼20 Å away from the active site and suggests a pathway for signal transduction between the heme and active sites. In this review, the spectroscopic and kinetic properties of the heme are discussed, which supports a regulatory role for this unexpected organometallic cofactor in a PLP-dependent enzyme.
- 12 March 2007
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 24 (3) , 631-639
Properties of an unusual heme cofactor in PLP-dependent cystathionine β-synthase
Covering: up to 2006 Cystathionine β-synthase is a pyridoxal phosphate (PLP)-dependent hemeprotein, which catalyzes the condensation of serine and homocysteine to give cystathionine, the first step in the transsulfuration pathway. The association of heme with this enzyme in some organisms, including humans, is novel since this combination of cofactors has not been seen in any other protein to date. While the role of PLP in the reaction is suggested by the beta replacement reaction that is catalyzed, the role of the heme is not yet well established. Spectroscopic studies reveal that the heme iron is coordinately saturated in the ferric and ferrous states and is relatively inert to ligand exchange in the oxidized state. The in vitro activity of cystathionine β-synthase is sensitive to the redox state of the heme and is higher in the ferric form. Both CO and NO bind to ferrous heme and inhibit the enzyme. The crystal structure of the protein reveals that the heme is ∼20 Å away from the active site and suggests a pathway for signal transduction between the heme and active sites. In this review, the spectroscopic and kinetic properties of the heme are discussed, which supports a regulatory role for this unexpected organometallic cofactor in a PLP-dependent enzyme.
- 12 July 2006
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 361 (1472) , 1333-1339
Quantum catalysis in B 12 -dependent methylmalonyl-CoA mutase: experimental and computational insights
B 12 -dependent methylmalonyl-CoA mutase catalyses the interchange of a hydrogen atom and the carbonyl-CoA group on adjacent carbons of methylmalonyl-CoA to give the rearranged product, succinyl-CoA. The first step in this reaction involves the transient generation of cofactor radicals by homolytic rupture of the cobalt–carbon bond to generate the deoxyadenosyl radical and cob(II)alamin. This step exhibits a curious sensitivity to isotopic substitution in the substrate, methylmalonyl-CoA, which has been interpreted as evidence for kinetic coupling. The magnitude of the isotopic discrimination is large and a deuterium isotope effect ranging from 35.6 at 20 °C to 49.9 at 5 °C has been recorded. Arrhenius analysis of the temperature dependence of this isotope effect provides evidence for quantum tunnelling in this hydrogen transfer step. The mechanistic complexity of the observed rate constant for cobalt–carbon bond homolysis together with the spectroscopically silent nature of many of the component steps limits the insights that can be derived by experimental approaches alone. Computational studies using a newly developed geometry optimization scheme that allows determination of the transition state in the full quantum mechanical/molecular mechanical coordinate space have yielded novel insights into the strategy deployed for labilizing the cobalt–carbon bond and poising the resulting deoxyadenosyl radical for subsequent hydrogen atom abstraction.
- 12 July 2006
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 361 (1472) , 1333-1339
Quantum catalysis in B 12 -dependent methylmalonyl-CoA mutase: experimental and computational insights
B 12 -dependent methylmalonyl-CoA mutase catalyses the interchange of a hydrogen atom and the carbonyl-CoA group on adjacent carbons of methylmalonyl-CoA to give the rearranged product, succinyl-CoA. The first step in this reaction involves the transient generation of cofactor radicals by homolytic rupture of the cobalt–carbon bond to generate the deoxyadenosyl radical and cob(II)alamin. This step exhibits a curious sensitivity to isotopic substitution in the substrate, methylmalonyl-CoA, which has been interpreted as evidence for kinetic coupling. The magnitude of the isotopic discrimination is large and a deuterium isotope effect ranging from 35.6 at 20 °C to 49.9 at 5 °C has been recorded. Arrhenius analysis of the temperature dependence of this isotope effect provides evidence for quantum tunnelling in this hydrogen transfer step. The mechanistic complexity of the observed rate constant for cobalt–carbon bond homolysis together with the spectroscopically silent nature of many of the component steps limits the insights that can be derived by experimental approaches alone. Computational studies using a newly developed geometry optimization scheme that allows determination of the transition state in the full quantum mechanical/molecular mechanical coordinate space have yielded novel insights into the strategy deployed for labilizing the cobalt–carbon bond and poising the resulting deoxyadenosyl radical for subsequent hydrogen atom abstraction.
- Open Access
- 1 May 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (19) , 13433-13438
Dynamics of Carbon Monoxide Binding to Cystathionine β-Synthase
- 1 May 2006
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (19) , 13433-13438
Open AccessDynamics of Carbon Monoxide Binding to Cystathionine β-Synthase